We can speculate that the increases in TNF-α, IL-1α, CXCL1, CCL2, and Th17 responses following testosterone GAHT therapy (121–126) could increase inflammation in periodontal tissues, potentially elevating periodontitis risk (121–126). This evidence concerns the gene TNF and periodontitis.